Antitrust & Competition Policy Blog

Editor: D. Daniel Sokol
University of Florida
Levin College of Law

A Member of the Law Professor Blogs Network

Tuesday, October 12, 2010

The AstraZeneca Judgment: Implications for IP and Regulatory Strategies

Posted by D. Daniel Sokol

David Hull (Covington) explains The AstraZeneca Judgment: Implications for IP and Regulatory Strategies.

ABSTRACT: In a judgment issued on 1 July 2010, the General Court largely upheld the Commission's decision imposing a €60 million fine on AstraZeneca for abusing its dominant position by engaging in certain IP and regulatory strategies aimed at protecting its product against generic competition and parallel imports from other Member States.

http://lawprofessors.typepad.com/antitrustprof_blog/2010/10/the-astrazeneca-judgment-implications-for-ip-and-regulatory-strategies.html

| Permalink

TrackBack URL for this entry:

http://www.typepad.com/services/trackback/6a00d8341bfae553ef0133f4ca8459970b

Listed below are links to weblogs that reference The AstraZeneca Judgment: Implications for IP and Regulatory Strategies:

Comments

Post a comment